MTOR and idiopathic pulmonary fibrosis: Numerous gene-related changes found in IPF, including mTOR activation and miR200 family downregulation, are known to increase expression of the lactate dehydrogenase (LDH)-A subunit which drives lactic acid production, and LDHA activity has been proposed as a target for IPF therapy [13, 15–17].